You searched for Parkinson's - Page 17 of 20

In Depth 12 Jul 2023

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

…to lowering the risk of Parkinson’s and other neurodegenerative diseases. The organization’s Microbiome Network enables members to collaborate on drug discovery, nutrition and probiotic development. A prominent player in the…

July 12, 2023 - 10 minutesmins - By Roohi Mariam Peter

In Depth 25 Jan 2024

The trends that will shape the biotech industry in 2024

…and extend research and development timelines. Furthermore, the use of stem cell technologies for purposes like drug testing, disease simulation, and the treatment of neurodegenerative diseases, such as Parkinson’s and…

January 25, 2024 - 13 minutesmins - By Jules Adam

Best in Biotech 21 May 2024

Eight companies spearheading Philadelphia’s biotech industry

…a T-regulatory (Treg) candidate focused on lung cancer targeting the FOXP3 gene. AUM LifeTech also develops a project targeting Parkinson’s disease. BlueWhale Bio BlueWhale Bio, a biotech company founded in…

May 21, 2024 - 10 minutesmins - By Jules Adam

News and Trends 7 Jun 2022

Yumanity selling neurology assets and merging with Kineta

…placed a partial clinical hold on multidose clinical trials of YTX-7739, currently being developed for the treatment of Parkinson’s disease. The FDA did not stop all clinical programming and allowed…

June 7, 2022 - 3 minutesmins - By Jim Cornall

Best in Biotech 31 Dec 2018

European Biotech’s Biggest News of 2018

…Lundbeck paying up to €900M in March for the Swiss biotech Prexton Therapeutics, which is developing a drug for Parkinson’s disease. Then there were the big deals and collaborations. Genentech…

December 31, 2018 - 12 minutesmins - By Jonathan Smith

Best in Biotech 22 May 2023

Five recent advancements in arthritis research over the past year

…conditions like Parkinson’s better, studying the oral microflora further, could be crucial in effectively treating gum diseases as well as rheumatoid arthritis. New drug could stop osteoarthritis from getting out…

May 22, 2023 - 8 minutesmins - By Roohi Mariam Peter

Best in Biotech 12 May 2023

Five latest advancements in Tourette’s syndrome research

…funding round last year. Closed-loop deep brain stimulation shows encouraging results as Tourette’s therapy Deep brain stimulation (DBS) has paved the way for transformative treatment approaches for Parkinson’s disease. Moreover,…

May 12, 2023 - 7 minutesmins - By Roohi Mariam Peter

In Depth 4 Jan 2018

A Crash Course in the Basics of Finance in Biotechnology

…might be switching from the first market approval of a CAR-T therapy to the latest strategy to protect crops from pests to a new anti-Parkinson’s drug. It can be hard…

January 4, 2018 - 5 minutesmins - By Alex Dale

News and Trends 13 Jul 2023

Gene therapy company EG 427 raises €18M

…or other neurodegenerative diseases such as multiple sclerosis or Parkinson’s disease. Pierre Denys, head of Urology department at R. Poincaré Hospital in Paris and co-founder of EG 427, said: “Neurogenic…

July 13, 2023 - 4 minutesmins - By Jim Cornall

danish biotech neurodegenerative alzheimers 1

News and Trends 20 Jul 2021

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

…treatments for Parkinson’s disease, multiple sclerosis, and frontotemporal dementia. Research in Alzheimer’s disease and in other neurodegenerative diseases has picked up in recent months, after a tough streak of more…

July 20, 2021 - 4 minutesmins - By Victor Kotsev

News and Trends 13 Jul 2022

Sanofi sells two portfolios of established products to Neuraxpharma

…across a large spectrum of diseases including depression, anxiety, psychosis, alcohol dependence, myasthenia gravis and Parkinson disease. The CNS portfolio notably includes Nozinan, Tranxene, Tiapridal, Dogmatil, Largactil. The pain and…

July 13, 2022 - 2 minutesmins - By Liza Laws

Interview 28 Oct 2022

Migraines: a new vaccine frontier beyond infectious diseases

…vaccines for chronic conditions such as migraines, Alzheimer’s and Parkinson’s — to name a few. By combining the power of mAbs and the convenience and affordability of vaccines, Vaxxinity’s synthetic…

October 28, 2022 - 7 minutesmins - By Omnia Ibrahim

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Search Results for: Parkinson's

Medicon Valley: how the initiative shaped biotech ecosystems in Denmark and Sweden

The trends that will shape the biotech industry in 2024

Eight companies spearheading Philadelphia’s biotech industry

Yumanity selling neurology assets and merging with Kineta

European Biotech’s Biggest News of 2018

Five recent advancements in arthritis research over the past year

Five latest advancements in Tourette’s syndrome research

A Crash Course in the Basics of Finance in Biotechnology

Gene therapy company EG 427 raises €18M

Danish Dementia Startup Launches Amid Maturing Nordic Biotech Scene

Sanofi sells two portfolios of established products to Neuraxpharma

Migraines: a new vaccine frontier beyond infectious diseases

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!